The largest database of trusted experimental protocols

Jupiter c18

Manufactured by Phenomenex
Sourced in United States, Germany, Japan

The Jupiter C18 is a reverse-phase HPLC column designed for the separation and analysis of a wide range of organic compounds. It features a spherical, high-purity silica support material with a chemical modification of octadecyl (C18) ligands. The column is suitable for use in various HPLC applications, providing efficient and reproducible chromatographic separations.

Automatically generated - may contain errors

61 protocols using jupiter c18

1

Purification of Peptides by Preparative HPLC

Check if the same lab product or an alternative is used in the 5 most similar protocols
For purification of peptides and peptide derivatives, a Waters preparative HPLC consisting of a 1525 pump module, 2707 autosampler, fraction collector III and a dual wavelength detector 2489 was used. The mobile phase was H2O/ACN containing 0.1% TFA (v/v). Columns Jupiter C18, 250 × 21.2 mm, 300 Å, 10 μm; Jupiter C18, 250 × 10.0 mm, 300 Å, 10 μm and Jupiter C4, 250 × 10.0 mm, 300 Å, 10 μm (all from Phenomenex, Aschaffenburg, Germany) were used as stationary phases.
+ Open protocol
+ Expand
2

Purification and Characterization of Synthetic Peptide

Check if the same lab product or an alternative is used in the 5 most similar protocols
Twenty-five mg of crude peptide dissolved in 25 mL of MilliQ water were loaded on Jupiter C18 (5 μm, 300 Å, 10 × 250 mm, Phenomenex) and separated in the following conditions: eluent A, 0.05% TFA in MilliQ water; eluent B, 0.05% TFA in CH3CN; gradient, from 0%B to 10%B in 2 min, and from 10%B to 40%B in 40 min; flow rate, 4 mL/min; detection at 214 nm. The chromatogram of purified peptide was carried out in the following conditions: column, Jupiter C18 (5 μm, 300 Å, 4.6 × 250 mm, Phenomenex); injection volume, 10 μL of 1 mg/mL peptide solution; flow rate, 1 mL/min; eluent A, 0.05% TFA in water; eluent B, 0.05% TFA in CH3CN; gradient, from 10%B to 30%B in 20 min, detection at 214 nm. The retention time results 11.6 min and the purity grade, 99%. Experimental mass: 2447.43 Da, Theoretical mass: 2447.79 Da (ESI-TOF, Mariner System 5220, Applied Biosystem, Perkin-Elmer, California, USA).
+ Open protocol
+ Expand
3

Peptide Purification and Characterization

Check if the same lab product or an alternative is used in the 5 most similar protocols
Thirty mg of crude peptide dissolved in 15 mL of MilliQ water were loaded on Jupiter C18 (5 μm, 300 Å, 10 × 250 mm, Phenomenex) and separated in the following conditions: eluent A, 0.05% TFA in MilliQ water; eluent B, 0.05% TFA in CH3CN; gradient, from 0%B to 5%B in 2 min, and from 5%B to 20%B in 45 min; flow rate, 4 mL/min; detection at 214 nm. The chromatogram of purified peptide was carried out in the following conditions: column, Jupiter C18 (5 μm, 300 Å, 4.6 × 250 mm, Phenomenex); injection volume, 10 μL of 1 mg/mL peptide solution; flow rate, 1 mL/min; eluent A, 0.05% TFA in water; eluent B, 0.05% TFA in CH3CN; gradient, from 10%B to 20%B in 20 min, detection at 214 nm. The retention time results 10.8 min and the purity grade, 99%. Experimental mass: 1232.75 Da, Theoretical mass: 1232.39 Da (ESI-TOF, Mariner System 5220, Applied Biosystem, Perkin-Elmer, California, USA).
+ Open protocol
+ Expand
4

Quantitative Proteomics by LC-MS/MS

Check if the same lab product or an alternative is used in the 5 most similar protocols
LC-MS/MS data were acquired on a Q-Exactive mass spectrometer (Thermo Scientific) coupled with a nanoAcquity UPLC system (Waters). Seven μL of peptide samples were injected and separated by a custom packed analytical C18 column (70 cm × 75 μm i.d., 3 um particle size of Jupiter C18, Phenomenex) in a 3 h gradient. The flow rate of the mobile phase (buffer A: 0.1% formic acid in water; buffer B: 0.1% formic acid in acetonitrile) was 300 nL/min. For peptide elution buffer B was increased to 12% at 36 min, 30% at 135 min, 45% at 175 min and finally 95% at 180 min. A data-dependent acquisition method was applied, in which a full MS scan was followed by up to 12 data-dependent MS/MS scans of the most abundant peptide precursors. A dynamic exclusion of 30 s was implemented to prevent repeated sequencing of previously selected peptides. For MS scans (400–2000 m/z; resolution of 35000 at 400 m/z), the automatic gain control (AGC) was set to 3-e6 with the maximum injection time (IT) of 20 ms. An isolation window of 2 m/z in the quadrupole was used for selecting precursor ions, which were fragmented by higher-energy collisional dissociation (HCD) at a normalized collision energy of 35. For MS/MS scans (200–2000 m/z with first fixed mass of 100 m/z; resolution of 17500 at 400 m/z), the AGC was set to 1-e5 and maximum IT was 100 ms.
+ Open protocol
+ Expand
5

Synthesis and Characterization of Gd-DOTA Conjugates

Check if the same lab product or an alternative is used in the 5 most similar protocols
The syntheses and characterization of SBK2-Tris-(Gd-DOTA)3 and scrambled-Tris-(Gd-DOTA)3 agents have been described previously [8 (link)]. Briefly, the peptides were synthesized using conventional solid-phase synthetic methods and FMOC-protected amino acids. Peptide purity was assessed using LC-MS/MS on a Thermo Finnigan LTQ Linear ion trap mass spectrometer with a Phenomenex Jupiter C18 reversed-phase capillary chromatography column. Peptides were conjugated to maleimido-tris-propargyl by reacting the N-terminal cysteine with the maleimide group. A copper-catalyzed azide-alkyne cycloaddition reaction was then used to couple azido-(Gd-DOTA) to the free alkyne groups of the tris-propargyl peptides. Matrix-assisted laser desorption/ionization time-of-flight (MALDI-TOF; Autoflex Speed, Bruker Corp., Billerica, MA, USA) was used to monitor the conjugation reaction of azido-(Gd-DOTA) to the peptide-tris-propargyl moieties. Gadolinium (Gd) content was measured using inductively coupled plasma optical emission spectroscopy (ICP-OES) (Agilent 730 Axial ICP-OES; Agilent Technologies, Wilmington, DE, USA). T1 relaxation constants for the agents were measured on the Bruker Biospec 9.4T MRI scanner (Bruker Corp., Billerica, MA, USA) at 37 °C.
+ Open protocol
+ Expand
6

Peptide Analysis by Orbitrap Fusion LC-MS/MS

Check if the same lab product or an alternative is used in the 5 most similar protocols
Peptides were reconstituted in water containing 0.2% formic acid and analysed by nanoflow-LC-MS/MS using an Orbitrap Fusion Mass spectrometer (Thermo Scientific) coupled to a Proxeon Easy-nLC 1000. Samples were injected on a 300 μm ID × 5 mm trap and separated on a 150 μm × 20 cm nano LC column (Jupiter C18, 3 μm, 300 A, Phenomenex). The separation was performed on a linear gradient from 7 to 30% acetonitrile, 0.2% formic acid over 105 minutes at 600 nl per min. Full MS scans were acquired from m/z 350 to m/z 1,500 at resolution 120,000 at m/z 200, with a target AGC of 1E6 and a maximum injection time of 200 ms. MS/MS scans were acquired in HCD mode with a normalized collision energy of 25 and resolution 30,000 using a Top 3 s method, with a target AGC of 5E3 and a maximum injection time of 3,000 ms. The MS/MS triggering threshold was set at 1E5 and the dynamic exclusion of previously acquired precursor was enabled for 20 s within a mass range of ±0.8 Da.
+ Open protocol
+ Expand
7

Synthesis and Purification of Tetrameric Peptide

Check if the same lab product or an alternative is used in the 5 most similar protocols

Example 2

Compound B was produced by solid-phase synthesis through standard Fmoc chemistry with a Syro multiple peptide synthesizer (MultiSynTech, Witten, Germany). The peptide was synthesized on TentaGel S RAM resin with Fmoc —NH-Cys(Trt)-COOH as first amino acid in C-terminus, Fmoc-NH-PEG(4)-CH2—CH2—COOH was added in second coupling step, then Fmoc-Lys(Fmoc)-OH was added twice to build the tetrameric core. Followed by the nine sequential additions of Fmoc amino acids to complete the peptide KKIRVRLSA. Side chain protecting groups were 2,2,4,6,7-pentamethyldihydrobenzofuran-5-sulfonyl for R, t-butoxycarbonyl for K and t-butyl for S. The final product was cleaved from the solid support and deprotected by treatment with TFA containing triisopropylsilane, water (95/2.5/2.5), and precipitated with diethyl ether. Crude peptides were purified by reversed-phase chromatography on a preparative column (XBridge peptide BEH C18 Waters), in linear gradient for 40 min, from 75% to 65% A, where A is 0.1% TFA/water and B is acetonitrile (rt=22 min). Final peptide purity and identity was confirmed by reversed phase chromatography on a Phenomenex Jupiter C18 analytical column (300 A°, 5 μm, 250×4.6 mm) with the same gradient as above and by mass spectrometry MALDI TOF/TOF (Ultraflex III Bruker Daltonics) (M+: found 7723, 5; calculated 7724, 1).

+ Open protocol
+ Expand
8

Reverse Phase HPLC and SDS-PAGE Analysis of Snake Venom

Check if the same lab product or an alternative is used in the 5 most similar protocols
One milligram of venom was subjected to reverse phase HPLC using a Waters system, Empower software, and a Phenomenex Jupiter C18 (250 × 4.6 mm, 5 μm, 300 Å pore size) column as outlined in Smith and Mackessy [88 (link)]. Protein/peptide was detected at 280 nm and 220 nm with a Waters 2487 Dual λ Absorbance Detector. Fractions corresponding to each peak were then frozen at − 80 °C overnight, lyophilized and then analyzed along with 20 μg crude venom via SDS-PAGE as described [88 (link)] in order to determine peak complexity, mass and toxin families [43 (link)]. Percent peak area at 280 nm was recorded as a proxy for relative toxin abundance.
+ Open protocol
+ Expand
9

Peptide Stability in Bronchoalveolar Lavage

Check if the same lab product or an alternative is used in the 5 most similar protocols
Bronchoalveolar lavage fluid (BAL) was collected from male and female C57BL/6 mice (4–5 months old) according to the procedure described in [31 (link),32 (link)]. Mice were euthanized by means of CO2 narcosis; a small incision at the level of the neck was made and a blunt needle connected to a syringe was inserted into the trachea. Then, lungs were washed with 1 mL of sterile PBS. BAL samples from each mouse were pooled, centrifuged at 1000 rpm (corresponding to 0.1× g) for 5 min, and stored at −80 °C. The supernatant was used for stability tests.
Peptides were dissolved in 400 µL of PBS at a concentration of 300 µM, and added to an equal volume of BAL at a final concentration of 150 µM. At different time points, 150 μL aliquots were withdrawn and added to 500 µL of acetonitrile, and then centrifuged. The supernatants were diluted with 160 μL of 0.1% trifluoroacetic acid (TFA)—water and analyzed by RP-HPLC and mass spectrometry. Liquid chromatography was performed on a Phenomenex Jupiter C18 analytical column (300 Å, 5 μm, 250 × 4.6 mm) in a 30 min gradient, using 0.1% TFA in water as solvent A and acetonitrile as solvent B. Mass spectrometry analysis of diluted samples was performed with a Bruker Daltonic-ultraflex-matrix-assisted laser desorption ionization tandem time-of-flight (MALDI-TOF/TOF) mass spectrometer.
+ Open protocol
+ Expand
10

Purification and Characterization of Naja atra Venom

Check if the same lab product or an alternative is used in the 5 most similar protocols
The lyophilized crude N. atra venom was dissolved in water and centrifuged at 10,000× g for 10 min. The amount of protein in the venom was determined via a BCA Protein Assay kit (PierceTM, Thermo Scientific). The supernatants were diluted and further purified by size exclusion chromatography. The purified venom proteins, NTXs, were isolated from the crude venom following the procedure described by Huang et al. [18 (link)]. All the venom protein components other than the NTXs were combined and dissolved in PBS, creating the deNTXs. The crude venom and deNTXs were loaded onto a Phenomenex Jupiter® C18 (250 × 4.6 mm, 5 µm particle size, 300 Å pore size) column with an ultraperformance liquid chromatography (UPLC) system (LC-20ADXR, Shimadzu, Kyoto, Japan) equipped with a DAD detector (SPD-M20A, Shimadzu, Kyoto, Japan) and autosampler (SIL-20ACXR, Shimadzu, Kyoto, Japan). The venom components were eluted at 1 mL/min with a linear gradient of 0.1% TFA in water (Solvent A) and 0.1% TFA in 100% ACN (Solvent B) (2% B for 5 min, followed by 2–10% B for 2 min, 10–16% B for 6 min, 16–28% B for 2 min and 28–65% B for 37 min) [18 (link)]. Protein elution was monitored at 215 nm (absorption wavelength for peptide bonds). The relative abundance (expressed as the percentage of the total venom protein) of each protein family was estimated as described by Huang et al. [18 (link)].
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!